Black Rock Inc. Palatin Technologies Inc Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.27 - $8.33 $841,614 - $26 Million	-3,117,089 Closed	0 $0
Q2 2022 Aug 12, 2022	BUY	$0.27 - $0.5 $3,434 - $6,360	12,720 Added 0.41%	3,117,089 $875,000
Q1 2022 May 12, 2022	BUY	$0.37 - $0.54 $749 - $1,093	2,025 Added 0.07%	3,104,369 $1.43 Million
Q4 2021 Feb 10, 2022	SELL	$0.34 - $0.86 $10,681 - $27,017	-31,416 Reduced 1.0%	3,102,344 $1.59 Million
Q3 2021 Nov 09, 2021	BUY	$0.44 - $0.63 $153 - $219	348 Added 0.01%	3,133,760 $1.39 Million
Q2 2021 Aug 11, 2021	BUY	$0.48 - $0.72 $1.5 Million - $2.26 Million	3,133,412 New	3,133,412 $1.91 Million

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $8.45M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.